论文信息 - GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1). - 字舞流文

GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1).

N. Derichs | P. Dřevínek | J. Davies | K. Conrath | O. Van de Steen | Lisa Allamassey | S. van Koningsbruggen-Rietschel | Herman A de Kock | F. Namour | E. McKone | D. Kanters